GlaxoSmithKline plc

    2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1995 1994 1993 1992 1991
Operating Cash Flow £7.95B£8.44B£8.02B£8.42B£6.92B£6.5B£2.57B£5.18B£7.22B£4.38B£6.25B£6.8B£7.84B£7.21B£6.17B£4.36B£5.96B£4.7B£4.85B£3.06B£4.61B£1.85B£510M£410M£615M£849M£1.25B£2.45B£1.05B£927M£657M£615M
Net Income £4.38B£5.75B£4.64B£3.62B£1.53B£912M£8.42B£2.76B£5.44B£4.57B£5.26B£1.63B£5.53B£4.71B£5.22B£5.39B£4.69B£4.3B£4.48B£3.94B£3.1B£4.16B£1.81B£1.84B£1.85B£2B£1.46B£1.04B£1.3B£1.21B£1.03B£881M
Depreciation & Amortization £2.52B£2.35B£2.33B£1.86B£1.92B£1.77B£1.63B£1.48B£1.41B£1.45B£1.42B£1.68B£1.56B£1.23B£1.02B£958.04M£903.7M£890.48M£859.04M£824M£812.8M£735M£428M£358M£373M£410M£533M£330.42M£282M£225M£191M£151M
Deferred Income Tax £0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0
Stock-Based Compensation £0£381M£365M£360M£333M£319M£368M£332M£319M£220M£198M£179M£179M£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0
Change In Working Capital £1.26B£2.43B£294M£3.42B£1.69B£3.99B£1.49B£757M£267M£-2.42B£-1.77B£2.78B£-151M£477M£-846.64M£-743.16M£-75.55M£-510.41M£-407.68M£941M£829.32M£297M£-278M£-552M£-207M£-302M£-46M£-60.03M£50M£4M£-73M£-116M
Other Non-Cash Items £-217M£-2.47B£382M£-841M£1.44B£-495M£-9.34B£-153M£-214M£565M£1.14B£528M£720M£785M£771.5M£-1.25B£441.1M£20.85M£-77.84M£-2.64B£-132.83M£-3.34B£-1.45B£-1.23B£-1.4B£-1.26B£-693M£1.14B£-578M£-509M£-494M£-301M
Cash From Investing £-1.78B£2.16B£-5.35B£-1.55B£-1.44B£-1.27B£6.04B£-1.08B£524M£-2.63B£-112M£-1.87B£-4.01B£-1.15B£-3.01B£-1.52B£-1.66B£-1.1B£-938.56M£-1.09B£-2.44B£-484M£-896M£-830M£-657M£-104M£-4.79B£-4.74B£-1.36B£-858M£-372M£-851M
Purchases Of Investments £0£-1M£-258M£-309M£4M£0£-2M£1M£-133M£-229M£-111M£-340M£-183M£-96M£-186M£-69.93M£-23M£-102.71M£-63M£-76M£-46.8M£-1.29B£-428M£-61M£-19M£-25M£-3M£0£-4M£-25M£-6M£0
Sales / Maturities of Investments £0£3.27B£1M£0£64M£683M£357M£205M£15M£224M£1.13B£118M£146M£947M£44.88M£32.16M£35M£57.87M£125M£123M£139.02M£495M£118M£54M£0£3M£37M£0£0£0£0£0
Property, Plant & Equipment Investments £-1.17B£-1.23B£-1.26B£-1.34B£-1.54B£-1.54B£-1.38B£-1.19B£-1.19B£-1.05B£-923M£-1.01B£-1.42B£-1.44B£-2.15B£-1.59B£-902.54M£-864.41M£-868M£-1.23B£-1.12B£-1.1B£-597M£-475M£-415M£-401M£-684M£-485.59M£-575M£-608M£-594M£-606M
Net Acquisitions £185M£3.01B£-3.78B£-292M£356M£592M£7.53B£235M£1.95B£-2.54B£-264M£-354M£-2.79B£-454M£-1.03B£-267.97M£-1.03B£-296.65M£-11.76M£-20M£-849.96M£66M£-29M£-152M£-38M£341M£-6.84B£0£-2M£-3M£0£0
Other Investing Activites £-790M£-2.89B£-52M£392M£-322M£-1B£-466M£-331M£-121M£960M£54M£-278M£234M£-109M£302.48M£374.64M£256.5M£102.19M£-120.8M£111M£-565.73M£1.35B£40M£-196M£-185M£-22M£2.7B£-4.26B£-782M£-222M£228M£-245M
Cash From Financing £-7.59B£-10.13B£-1.84B£-6.39B£-6.38B£-6.39B£-7.1B£-5.38B£-6.27B£-3.35B£-6.23B£-5.57B£-2.77B£-4.91B£-1.74B£-4.79B£-2.91B£-3.93B£-3.94B£-1.57B£-2.78B£-546M£350M£339M£-59M£-658M£3.66B£2.18B£39M£96M£-466M£473M
Debt Repayment £-2B£-7.3B£-4.16B£-2.07B£-3.2B£-919M£-2.41B£-1.71B£-1.87B£-2.56B£-8M£-1.34B£-796M£-3.11B£-207M£-739M£-927M£-422M£0£-631M£0£-756M£-9M£-63M£-504M£-1.25B£-7.29B£0£-1.65B£-1.88B£-1.56B£-1.86B
Dividend Payments £-4B£-3.98B£-3.95B£-3.93B£-3.91B£-4.85B£-3.87B£-3.84B£-3.68B£-3.81B£-3.41B£-3.21B£-3.09B£-3.01B£-2.8B£-2.6B£-2.48B£-2.47B£-2.33B£-2.33B£-2.33B£0£0£0£0£0£0£-844.08M£0£0£0£0
Payout Ratio 91.2%69.18%85.1%108.39%254.96%531.8%46%139.44%67.7%83.55%64.74%196.14%55.9%63.84%53.57%48.2%52.8%57.53%52.03%59.14%75.18%0%0%0%0%0%0%81.22%0%0%0%0%
Net Common Stock Repurchased £-21M£-29M£-51M£-74M£9M£-15M£26M£166M£964M£2.12B£1.93B£-63M£1M£3.65B£3.22B£880.46M£679.38M£1.42B£938M£2.16B£1.59B£-185M£-104M£-284M£-188M£-215M£-106M£-44.08M£-51M£-69M£-24M£-20M
Common Stock Repurchased £0£0£0£0£-65M£-74M£-99M£-333M£-1.55B£-2.53B£-2.23B£-16M£-57M£-3.73B£-3.75B£-1.35B£-999.01M£-1.49B£-978.88M£-2.22B£-1.74B£0£0£0£0£0£0£0£0£0£0£0
Common Stock Issued £-21M£-29M£-51M£-74M£9M£-15M£26M£166M£964M£2.12B£1.93B£-63M£1M£3.65B£3.22B£880.46M£679.38M£1.42B£938M£2.16B£1.59B£-185M£-104M£-284M£-188M£-215M£-106M£-44.08M£-51M£-69M£-24M£-20M
Other Financing Activites £-1.62B£1.12B£6.22B£-469M£735M£-638M£-791M£333M£243M£5.14B£-886M£-1.09B£1.11B£4.86B£4.48B£-574.28M£1.17B£386.03M£-672M£3.56B£1.14B£25M£255M£118M£257M£382M£10.84B£2.98B£1.64B£1.9B£1.07B£2.31B
Accounts Receivables £0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0
Accounts Payables £0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0
Inventory £0£119M£300M£51M£-461M£70M£-111M£-529M£-95M£37M£-157M£238M£-132M£-411M£-457.35M£-298.08M£47.07M£-32.85M£-76.16M£-2M£252.58M£-16M£-391M£-297M£-184M£-96M£8M£44.08M£5M£29M£-47M£-57M
Other Working Capital £0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0£0
Capital Expenditure (CAPEX) £-2.93B£-2.24B£-2.16B£-1.8B£-2.2B£-2.35B£-1.9B£-1.75B£-1.7B£-1.52B£-1.33B£-1.64B£-1.87B£-2.07B£-2.15B£-1.59B£-902.54M£-864.41M£-868M£-1.23B£-1.12B£-1.1B£-597M£-475M£-415M£-401M£-684M£-485.59M£-575M£-608M£-594M£-606M
Effect Of Foreign Exchange On Cash £-29M£-39M£-82M£8M£-100M£283M£-45M£84M£-148M£-92M£-108M£81M£-158M£1.1B£47.9M£-253.67M£233.05M£0£0£-146M£0£-23M£10M£-30M£-1M£177M£4M£-3.01M£18M£-32M£72M£-9M
Net Change In Cash £-1.44B£431M£744M£487M£-1B£-881M£1.46B£-1.2B£1.32B£-1.7B£-202M£-561M£896M£2.25B£1.46B£-2.21B£1.62B£-335.76M£-26.88M£-893M£-613.21M£799M£-26M£-111M£-102M£264M£119M£2.18B£-253M£133M£-109M£228M
Free Cash Flow (FCF) £5.02B£6.2B£5.86B£6.63B£4.72B£4.14B£668M£3.42B£5.52B£2.85B£4.92B£5.16B£5.97B£5.14B£4.02B£2.77B£5.05B£3.84B£3.98B£1.83B£3.49B£749M£-87M£-65M£200M£448M£568M£1.96B£478M£319M£63M£9M
Free Cash Flow To Equity (FCFE) £3.03B£-1.1B£1.7B£4.56B£1.52B£3.23B£-1.74B£1.72B£3.65B£296M£4.91B£3.82B£5.17B£2.03B£3.81B£2.03B£4.13B£3.41B£3.98B£1.2B£3.49B£-7M£-96M£-128M£-304M£-807M£-6.72B£1.96B£-1.17B£-1.56B£-1.5B£-1.85B

Copyright © 2022 STOCKROUTINES